InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Sunday, 09/20/2020 7:30:57 PM

Sunday, September 20, 2020 7:30:57 PM

Post# of 3872
BCYC-Presentations
ESMO
SEPTEMBER 17, 2020
BT8009-100 Phase I/II Study of the Safety, Pharmacokinetics, & Preliminary Clinical Activity of BT8009 in Patients with Nectin-4 Expressing Advanced Malignancies
https://www.bicycletherapeutics.com/publications/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News